Premium
Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1–3? 1
Author(s) -
ZWAGINGA J. J.,
SAKARIASSEN K. S.,
KING M. R.,
DIACOVO T. G.,
GRABOWSKI E. F.,
NASH G.,
HOYLAERTS M.,
HEEMSKERK J. W. M.
Publication year - 2007
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2007.02807.x
Subject(s) - von willebrand disease , von willebrand factor , disease , medicine , computational biology , immunology , biology , platelet
J . J . ZWAGINGA,* K . S . SAKAR IASSEN , M. R . K ING , T . G . D IACOVO,§ E . F . GRABOWSK I ,– G. NASH,** M. H OY LAERTS , J . W . M. HEEMSKER K and THE B IORHEOLOGY SUBCOMMITTEE OF THE SSC OF THE I STH *Department of Experimental Immunohaematology, Sanquin Research, Amsterdam and Immunohaematology Bloodtransfusion, University Hospital Leiden, Leiden, the Netherlands; KellSa s.a.s., Biella, Italy; Department of Biomedical Engineering, University of Rochester, Rochester, New York, NY; §Departments of Pediatrics and Pathology, Columbia University Medical Center, New York, NY; –Cardiovascular Thrombosis Laboratory, Massachusetts General Hospital–Harvard Medical School, Boston, MA, USA; **Centre for Cardiovascular Sciences and MRC Centre for Immune Regulation, University of Birmingham, Birmingham, UK; Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium; and Department of Biochemistry, CARIM, University of Maastricht, Maastricht, the Netherlands